Clinical Trial Update: Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing JW-100 and EUCRISA for atopic dermatitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Eucrisa (crisaborole)
• JW-100

Snippet

Sponsor: Applied Biology, Inc. | Conditions: Atopic Dermatitis | Phase 3 | Status: WITHDRAWN